These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2176727)

  • 1. Stimulation of the hypothalamic-pituitary-adrenal axis by epidermal growth factor.
    Miyabo S; Ooya E; Miyanaga K; Aoyagi N; Hirai M; Kishida S; Nakai T
    Regul Pept; 1990 Oct; 31(1):65-74. PubMed ID: 2176727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation of the hypothalamo-pituitary-adrenal axis in the rat by the type 4 phosphodiesterase (PDE-4) inhibitor, denbufylline.
    Hadley AJ; Kumari M; Cover PO; Osborne J; Poyser R; Flack JD; Buckingham JC
    Br J Pharmacol; 1996 Oct; 119(3):463-70. PubMed ID: 8894165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The muscarinic cholinergic agonist arecoline stimulates the rat hypothalamic-pituitary-adrenal axis through a centrally-mediated corticotropin-releasing hormone-dependent mechanism.
    Calogero AE; Kamilaris TC; Gomez MT; Johnson EO; Tartaglia ME; Gold PW; Chrousos GP
    Endocrinology; 1989 Nov; 125(5):2445-53. PubMed ID: 2551652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of epidermal growth factor with the hypothalamic-pituitary-adrenal axis: potential physiologic relevance.
    Luger A; Calogero AE; Kalogeras K; Gallucci WT; Gold PW; Loriaux DL; Chrousos GP
    J Clin Endocrinol Metab; 1988 Feb; 66(2):334-7. PubMed ID: 2828409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The kappa-opioid receptor agonist MR-2034 stimulates the rat hypothalamic-pituitary-adrenal axis: studies in vivo and in vitro.
    Calogero AE; Scaccianoce S; Burrello N; Nicolai R; Muscolo LA; Kling MA; Angelucci L; D'Agata R
    J Neuroendocrinol; 1996 Aug; 8(8):579-85. PubMed ID: 8866244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cocaine- and amphetamine-regulated transcript activates the hypothalamic-pituitary-adrenal axis through a corticotropin-releasing factor receptor-dependent mechanism.
    Smith SM; Vaughan JM; Donaldson CJ; Rivier J; Li C; Chen A; Vale WW
    Endocrinology; 2004 Nov; 145(11):5202-9. PubMed ID: 15271883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 5-hydroxytryptamine2 agonist, (+-)-1-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane stimulates the hypothalamic-pituitary-adrenal (HPA) axis. I. Acute effects on HPA axis activity and corticotropin-releasing factor-containing neurons in the rat brain.
    Owens MJ; Knight DL; Ritchie JC; Nemeroff CB
    J Pharmacol Exp Ther; 1991 Feb; 256(2):787-94. PubMed ID: 1847212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of vindesine on hypothalamic-pituitary-adrenal axis.
    Brunetti L; Preziosi P; Ragazzoni E; Vacca M
    Toxicol Lett; 1995 Jan; 75(1-3):69-73. PubMed ID: 7863539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of the hypothalamo-pituitary-adrenal axis by the growth hormone (GH) secretagogue, GH-releasing peptide-6, in rats.
    Thomas GB; Fairhall KM; Robinson IC
    Endocrinology; 1997 Apr; 138(4):1585-91. PubMed ID: 9075719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of chronic maternal dexamethasone treatment on the hormones of the hypothalamo-pituitary-adrenal axis in the rat fetus.
    Dupouy JP; Chatelain A; Boudouresque F; Conte-Devolx B; Oliver C
    Biol Neonate; 1987; 52(4):216-22. PubMed ID: 2823915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of corticotropin-releasing hormone in gastrin-releasing peptide-mediated regulation of corticotropin and corticosterone secretion in male rats.
    Garrido MM; Martin S; Ambrosio E; Fuentes JA; Manzanares J
    Neuroendocrinology; 1998 Aug; 68(2):116-22. PubMed ID: 9705578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recovery of the hypothalamo-pituitary-adrenocortical axis in the rat after long-term dexamethasone treatment.
    Nicholson S; Campbell E; Torrellas A; Beckford U; Altaher R; Sandford R; Scraggs R; Gillham B; Jones M
    Neuroendocrinology; 1984 Oct; 39(4):343-9. PubMed ID: 6092989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consequences of prenatal morphine exposure on the hypothalamo-pituitary-adrenal axis in the newborn rat: effect of maternal adrenalectomy.
    Lesage J; Grino M; Bernet F; Dutriez-Casteloot I; Montel V; Dupouy JP
    J Neuroendocrinol; 1998 May; 10(5):331-42. PubMed ID: 9663647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypothalamus, anterior pituitary and adrenal gland involvement in the activation of adrenocorticotropin and corticosterone secretion by gastrin-releasing peptide.
    Garrido MM; Manzanares J; Fuentes JA
    Brain Res; 1999 May; 828(1-2):20-6. PubMed ID: 10320721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of 5-HT1A receptor agonists on hypothalamo-pituitary-adrenal axis activity and corticotropin-releasing factor containing neurons in the rat brain.
    Owens MJ; Edwards E; Nemeroff CB
    Eur J Pharmacol; 1990 Nov; 190(1-2):113-22. PubMed ID: 1963847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 5-hydroxytryptamine2 agonist, (+-)-1-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane stimulates the hypothalamic-pituitary-adrenal (HPA) axis. II. Biochemical and physiological evidence for the development of tolerance after chronic administration.
    Owens MJ; Knight DL; Ritchie JC; Nemeroff CB
    J Pharmacol Exp Ther; 1991 Feb; 256(2):795-800. PubMed ID: 1847213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of lithium on the hypothalamo-pituitary-adrenal axis.
    Sugawara M; Hashimoto K; Hattori T; Takao T; Suemaru S; Ota Z
    Endocrinol Jpn; 1988 Oct; 35(5):655-63. PubMed ID: 2851438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of hypothalamic-pituitary-adrenal axis responsiveness to stress in a rat model of acute cholestasis.
    Swain MG; Patchev V; Vergalla J; Chrousos G; Jones EA
    J Clin Invest; 1993 May; 91(5):1903-8. PubMed ID: 8387536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of the hypothalamo-pituitary-adrenal axis in the rat by three selective type-4 phosphodiesterase inhibitors: in vitro and in vivo studies.
    Kumari M; Cover PO; Poyser RH; Buckingham JC
    Br J Pharmacol; 1997 Jun; 121(3):459-68. PubMed ID: 9179387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of platelet-activating factor on hypothalamic and hypophyseal pro-opiomelanocortin-related peptides and hypothalamo-pituitary-adrenal axis in the rat.
    Blasquez C; Jégou S; Delarue C; Delbende C; Bunel DT; Braquet P; Vaudry H
    Eur J Pharmacol; 1990 Feb; 177(3):145-53. PubMed ID: 2155805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.